eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2010
vol. 14
 
Share:
Share:
abstract:
Original paper

Analysis of pharmacokinetics and PK/PD parameter Cmax/MIC for ciprofloxacin in patients with neutropenic fever

Edyta Szałek
,
Agnieszka Kamińska
,
Anna Łojko
,
Edmund Grześkowiak
,
Mieczysław Komarnicki
,
Dawid Murawa
,
Katarzyna Nabywaniec

Współczesna Onkologia (2010) vol. 14;4 (286-290)
Online publish date: 2010/09/09
View full text Get citation
 
PlumX metrics:
Background: The antimicrobial efficacy of chemotherapeutics is determined by their pharmacokinetic/pharmacodynamic properties (PK/PD). To estimate the efficacy of an antibiotic therapy three basic markers were established: the ratio between peak antibiotic concentration obtained after a single dose and the minimum inhibitory concentration (Cmax/MIC) for e.g. fluoroquinolones, the ratio between the area under the curve of serum concentration within the 24-hour time limit and MIC (AUC24/MIC) for e.g. tetracyclines, and the time when the concentration remains above the MIC (T > MIC) for e.g. -lactams.
Aim of study: The aim of the study was to analyse the pharmacokinetics and PK/PD parameter Cmax/MIC for ciprofloxacin in patients with neutropenic fever.
Material and methods: The study was conducted on 6 patients with neutropenic fever with identified bacteria, hospitalized because of multiple myeloma (n = 4), non-Hodgkin lymphoma (n = 1), or acute granulocytic leukaemia (n = 1). The patients were treated with ciprofloxacin in the dose of 200 mg/12 h (i.v.). Plasma concentrations of ciprofloxacin after the first dose (Cmax1) and at steady state (Cssmax, Cssmin) were measured by a validated HPLC method with UV detection.
Results: The maximum concentrations after the first dose (Cmax1) (mean ± standard deviation) and the maximum and minimum concentrations at steady state were Cmax1 = 1.620 (± 1.050) µg/ml, Cssmax1 = 2.087 (± 0.990) µg/ml, Cssmin = 0.618 (± 0.602) µg/ml. The mean Cmax1/MIC ratio and Cssmax/MIC were: 1.241 (± 1.341) and 2.183 (± 2.274).
Conclusions: The low values of Cmax/MIC for ciprofloxacin in the analysed patients indicate too low drug concentrations in the blood in comparison with the MIC of pathogens and the need of PK/PD monitoring in order to carry out initial evaluation of the applied treatment and to verify the established dosing regimen.
keywords:

ciprofloxacin, pharmacokinetics, pharmacodynamics, neutropenic fever

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.